Adaptation of a commercially available module for the production of alpha-[11C]methyl-L-tryptophan ([11C]AMT) for human use

Résumé fourni par la source

The complex radiosynthesis of alpha-[ 11 C]methyl-L-tryptophan ([ 11 C]AMT) involves harsh chemicals and conditions, posing challenges for its implementation on commercially available synthesis modules. This study describes the adaptation of the GE TRACERlab FX2 C module for [ 11 C]AMT production using both a half-manual approach and a semi-automated method incorporating a 16-way valve system. [ 11 C]AMT was synthesized with decay-corrected radiochemical yields of 13 ± 7.5 % (half-manual) and 10.4 ± 4.1 % (semi-automated), with radiochemical purities exceeding 95 %. The half-manual approach demonstrated higher reliability in synthesis success but required increased operator intervention, while the semi-automated method minimized radiation exposure to the operator. Key factors influencing synthesis success included the preparation and precise addition of lithium diisopropylamide and the use of a soda lime column to mitigate iodine contamination during [ 11 C]CH 3 I transfer. This work presents a practical and scalable solution for producing [ 11 C]AMT on a commercially available module, enabling its broader application in clinical research, particularly in brain imaging and pediatric oncology.

Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.